Related Experiment Video
Updated: Mar 10, 2026

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions
Published on: April 21, 2016
Impaired prohormone processing: a grand unified theory for features of Prader-Willi syndrome?
Insights
Prader-Willi syndrome (PWS) may stem from reduced prohormone convertase 1 (PC1) expression. This study used patient-derived neurons and mouse models to link PC1 deficiency to PWS neuroendocrine phenotypes.
Area of Science:
- Genetics
- Neuroendocrinology
- Molecular Biology
Background:
- Prader-Willi syndrome (PWS) presents diverse phenotypes, including hypotonia, feeding issues, hyperphagia, and developmental delays.
- The genetic basis of PWS is known, but the molecular mechanisms driving its complex phenotypes remain unclear.
Purpose of the Study:
- To investigate the molecular mechanisms underlying Prader-Willi syndrome phenotypes.
- To explore the role of prohormone convertase 1 (PC1) in PWS pathogenesis.
Main Methods:
- Utilized induced pluripotent stem cells (iPSCs) from PWS patients to derive neurons.
- Employed PWS mouse models for comprehensive analysis.
- Assessed the expression levels of prohormone convertase 1 (PC1).
Main Results:
- Provided evidence linking reduced prohormone convertase 1 (PC1) expression to neuroendocrine phenotypes in PWS.
- Demonstrated a potential role for PC1 deficiency in the manifestation of PWS symptoms.
Conclusions:
- Reduced PC1 expression is a potential key factor in PWS neuroendocrine dysfunction.
- Further research is necessary to fully elucidate the contribution of PC1 deficiency to PWS.
- These findings offer new insights into the molecular basis of Prader-Willi syndrome.
Abstract:
Prader-Willi syndrome (PWS) is a complex disorder that manifests with an array of phenotypes, such as hypotonia and difficulties in feeding during infancy and reduced energy expenditure, hyperphagia, and developmental delays later in life. While the genetic cause has long been known, it is still not clear how mutations at this locus produce this array of phenotypes. In this issue of the JCI, Burnett and colleagues used a comprehensive approach to gain insight into how PWS-associated mutations drive disease. Using neurons derived from PWS patient induced pluripotent stem cells (iPSCs) and mouse models, the authors provide evidence that neuroendocrine PWS-associated phenotypes may be linked to reduced expression of prohormone convertase 1 (PC1). While these compelling results support a critical role for PC1 deficiency in PWS, more work needs to be done to fully understand how and to what extent loss of this prohormone processing enzyme underlies disease manifestations in PWS patients.
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Inborn Errors of Metabolism
Pleiotropy
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Abnormal Proliferation
Sex-linked Disorders

